Report #2841008

Received May 14, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (NO BRAND NAME)	UNKNOWN MANUFACTURER	UNK	UNK	—

Symptoms (1)

Injection site pain

Symptom narrative

local site injection soreness; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced injection site pain (Verbatim: local site injection soreness). The outcome of the injection site pain was not reported. It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine. It was unknown if the company considered the injection site pain to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 09-MAY-2025 This case was reported by a patient via interactive digital media. It was reported as none at all. The patient had Just a little local site injection soreness. The patient got protected soon.